| Literature DB >> 33059705 |
G Ahlström1, A Axmon2, M Sandberg3, E Flygare Wallén4,5.
Abstract
BACKGROUND: Specific medical guidelines for health surveillance exist for people with Down syndrome (DS) since 25 years but knowledge of adherence to the guidelines is lacking. The guidelines were developed to avoid unnecessary suffering from preventable conditions. The aims of the study were to investigate 1) planned health care visits in relation to the co-morbidities described in specific medical guidelines as a measure of adherence, 2) unplanned health care visits as a measure of potentially unmet health care needs and 3) gender differences in health care utilisation among older people with DS.Entities:
Keywords: Aged; Comorbidity; Down syndrome; Guideline adherence; Inpatients; Intellectual disability; Mental retardation; Outpatient care; Specialist health care
Mesh:
Year: 2020 PMID: 33059705 PMCID: PMC7559468 DOI: 10.1186/s12913-020-05800-7
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Health care visits for 472 older adults with Down syndrome during 11 years study period at the ten most visited clinics (total and different types of health care visits)
| Total people with DS | Total health care visits | Planned health care visits | Unplanned health care visits | Unknown health care visits | Outpatient health care visits | Inpatient health care visits | |
|---|---|---|---|---|---|---|---|
| Internal medicine | 259 (54.9) | 791 (20.5) | 157 (7.5) | 621 (36.6) | 13 (23.2) | 306 (11.9) | 485 (38.1) |
| Ophthalmology | 212 (44.9) | 664 (17.2) | 618 (29.4) | 33 (1.9) | 13 (23.2) | 613 (23.7) | 51 (4.0) |
| Surgery | 170 (36.0) | 484 (12.6) | 194 (9.2) | 284 (16.8) | 6 (10.7) | 285 (11.0) | 199 (15.6) |
| Orthopaedic clinic | 157 (33.3) | 467 (12.1) | 274 (13.0) | 187 (11.0) | 6 (10.7) | 337 (13.1) | 130 (10.2) |
| General psychiatric clinic | 50 (10.6) | 197 (5.1) | 130 (6.2) | 57 (3.4) | 10 (17.9) | 166 (6.4) | 31 (2.4) |
| Ear, nose and throat clinic | 80 (16.9) | 191 (5.0) | 139 (6.6) | 50 (2.9) | 2 (3.6) | 158 (6.1) | 33 (2.6) |
| Emergency department | 79 (16.7) | 168 (4.4) | 8 (0.4) | 160 (9.4) | 0 (0) | 152 (5.9) | 16 (1.3) |
| Infectious diseases | 68 (14.4) | 114 (3.0) | 12 (0.6) | 102 (6.0) | 0 (0) | 18 (0.7) | 96 (7.5) |
| Geriatrics and geropsychiatrics | 61 (12.9) | 158 (4.1) | 140 (6.6) | 17 (1.0) | 1 (1.8) | 136 (5.3) | 22 (1.7) |
| Neurological clinic | 40 (8.5) | 93 (2.4) | 69 (3.3) | 24 (1.4) | 0 (0) | 67 (2.6) | 26 (2.0) |
Note: If multiple visits are recorded, only one visit per person, clinic and day is included
Primary diagnoses listed in specific medical guidelines, present for planned and unplanned visits for 472 older adults with Down syndrome (225 women and 247 men) with at least one visit in health care
| Planned | Unplanned | |||||||
|---|---|---|---|---|---|---|---|---|
| Median | Q1-Q3 | Min-max | Median | Q1-Q3 | Min-max | |||
| Arthrosis (M15-M19) | ||||||||
| Total | 42 (8.9) | 2 | 1–2 | 1–5 | 12 (2.5) | 1 | 1–1 | 1–2 |
| Women | 30 (13.3) | 2 | 1–2 | 1–5 | 9 (4.0) | 1 | 1–1 | 1–2 |
| Men | 12 (4.9) | 1 | 1–4 | 1–5 | 3 (1.2) | 1 | 1–1 | 1–1 |
| Cataract (H25-H26) | ||||||||
| Total | 155 (32.) | 1 | 1–2 | 1–3 | 8 (1.7) | 1 | 1–1 | 1–1 |
| Women | 90 (40.0) | 1 | 1–2 | 1–3 | 5 (2.2) | 1 | 1–1 | 1–1 |
| Men | 65 (26.3) | 1 | 1–2 | 1–3 | 3 (1.2) | 1 | 1–1 | 1–1 |
| Constipation (K59) | ||||||||
| Total | 11 (2.3) | 1 | 1–1 | 1–3 | 22 (4.7) | 1 | 1–2 | 1–7 |
| Women | 6 (2.7) | 1 | 1–1 | 1–1 | 11 (4.9) | 1 | 1–2 | 1–7 |
| Men | 5 (2.0) | 1 | 1–2 | 1–3 | 11 (4.5) | 1 | 1–1 | 1–3 |
| Dementia (F00, F03.9, G30) | ||||||||
| Total | 31 (6.6) | 1 | 1–2 | 1–4 | ||||
| Women | 20 (8.9) | 1 | 1–2 | 1–3 | ||||
| Men | 11 (4.5) | 1 | 1–2 | 1–4 | ||||
| Diabetes mellitus (E10-E14) | ||||||||
| Total | 15 (3.2) | 1 | 1–3 | 1–11 | ||||
| Women | 8 (3.6) | 1 | 1–2 | 1–11 | ||||
| Men | 7 (2.8) | 2 | 1–3 | 1–3 | ||||
| Epilepsy or seizure (G40-G41, R56.8) | ||||||||
| Total | 42 (8.9) | 1 | 1–2 | 1–6 | 93 (19.7) | 1 | 1–2 | 1–30 |
| Women | 32 (14.2) | 1 | 1–2 | 1–6 | 62 (27.6) | 1 | 1–2 | 1–30 |
| Men | 10 (4.1) | 1 | 1–2 | 1–3 | 31 (12.6) | 1 | 1–1 | 1–4 |
| Hearing loss (H90-H91) | ||||||||
| Total | 10 (2.1) | 1 | 1–1 | 1–2 | ||||
| Women | 3 (1.3) | 1 | 1–1 | 1–1 | ||||
| Men | 7 (2.8) | 1 | 1–1 | 1–2 | ||||
| Impacted cerumen (H61.2) | ||||||||
| Total | 19 (4.0) | 1 | 1–1 | 1–5 | ||||
| Women | 9 (4.0) | 1 | 1–1 | 1–2 | ||||
| Men | 10 (4.0) | 1 | 1–1 | 1–5 | ||||
| Keratoconus (H18.6) | ||||||||
| Total | 11 (2.3) | 1 | 1–2 | 1–2 | ||||
| Women | 4 (1.8) | 1 | 1–2 | 1–2 | ||||
| Men | 7 (2.8) | 1 | 1–2 | 1–2 | ||||
| Pneumonia (J12-J15, J18, J69.0) | ||||||||
| Total | 128 (27.1) | 1 | 1–1 | 1–5 | ||||
| Women | 46 (20.4) | 1 | 1–1 | 1–5 | ||||
| Men | 82 (33.2) | 1 | 1–2 | 1–4 | ||||
Note: Only diagnoses recorded for at least 10 people (planned and unplanned separately) are included. Excluded from the table due to too few observations: atlanto-axial instability (S13.4), coeliac disease (K90), depression (F32-F33), gastro-oesophageal reflux (K21), heart and lung symptoms (I20-I52), obesity (E65-E66), osteoporosis (M80-M81), sleep apnoea (G47.3), testicular cancer (C62), thyroid disorders (E039), and skin disease (L00-L99)
Number and percentage of the four most frequent primary diagnosis (main causes) recorded for an unplanned visit, and its occurrence in planned visits for older adults with Down syndrome (total n = 472, 225 women and 247 men)
| Planned | Unplanned | |||||||
|---|---|---|---|---|---|---|---|---|
| Median | Q1-Q3 | Min-Max | Median | Q1-Q3 | Min-Max | |||
| Pneumonia (J12–15, J18, J69.0) | ||||||||
| Total | 128 (27.1) | 1 | 1–2 | 1–5 | ||||
| Women | 46 (20.4) | 1 | 1–2 | 1–5 | ||||
| Men | 82 (33.2) | 1 | 1–2 | 1–4 | ||||
| Epilepsy or seizure (G40-G41, R56.8) | ||||||||
| Total | 42 (8.9) | 1 | 1–2 | 1–6 | 93 (19.7) | 1 | 1–2 | 1–30 |
| Women | 32 (14.2) | 1 | 1–2 | 1–6 | 62 (27.6) | 1 | 1–2 | 1–30 |
| Men | 10 (4.1) | 1 | 1–2 | 1–3 | 31 (12.6) | 1 | 1–1 | 1–4 |
| Pain (M79.6, R07, R10, R52) | ||||||||
| Total | 31 (6.6) | 1 | 1–1 | 1–4 | 127 (26.9) | 1 | 1–2 | 1–35 |
| Women | 20 (8.9) | 1 | 1–1 | 1–4 | 66 (29.3) | 1 | 1–2 | 1–35 |
| Men | 11 (4.5) | 1 | 1–1 | 1–1 | 61 (24.7) | 1 | 1–1 | 1–5 |
| Fractures (S02-S92) | ||||||||
| Total | 67 (14.2) | 1 | 1–2 | 1–4 | 124 (26.3) | 1 | 1–2 | 1–5 |
| Women | 44 (19.6) | 1 | 1–2 | 1–4 | 72 (32.0) | 1 | 1–2 | 1–5 |
| Men | 23 (9.3) | 1 | 1–1 | 1–2 | 52 (21.1) | 1 | 1–2 | 1–3 |
Note: Only diagnoses recorded for at least 10 people (planned and unplanned separately) are included
Medical guidelines of health checks for optimal medical care of adults with Down syndrome
| International [ | Norway [ | Sweden [ | |
|---|---|---|---|
| Alzheimer’s disease (dementia) | X | X | |
| Arthrosis | X | ||
| Atlantoaxial Instability | X | X | Yearly |
| Autism/ADHD | X | ||
| Autoimmune disorders e.g., coeliac disease | X | X | X |
| Behavioural change | X | Yearly | |
| Blood screening | Yearly | Yearly | |
| Cardiac and lung evaluation i.e., mitral valve prolapse, aortic regurgitation and pulmonary artery hypertension | X | X | Yearly |
| Contraceptive for females | X | ||
| Cervical spine | X | Yearly | |
| Dental care/oral health | X | Every 6 months | Yearly |
| Depression/anxiety | X | X | |
| Diabetes (blood glucose) | Yearly | ||
| Emotional support | X | ||
| Epilepsy, life periods with increased risk | 3rd, 5th and 6th decade | X | |
| Eye examination i.e., cataract, refraction error, other eye disorders | Every 2 years | Yearly/ specialist every 5th year | Every three years until age 25 |
| Gastrointestinal disorders i.e., dysphagia, oesophageal reflux, constipation, Hirschsprung’s disease | Yearly | Yearly | |
| Hearing examination (hearing loss) conductive/sensorineural | Every 2 years | Yearly | Yearly |
| Infectious diseases such as pneumonia and influenza | Yearly | Yearly | |
| National screenings | X | ||
| Nutrition | X | Yearly | |
| Obesity | X | Yearly | |
| Orthopaedic problems (hips/knee/feet/spine) | X | Yearly | |
| Osteoporosis | X | ||
| Psychosocial motor and mental disorder | X | ||
| Skin diseases i.e., alopecia, vitiligo, dermatitis, psoriasis | X | ||
| Sleep, i.e., obstructive sleep apnoea syndrome | Yearly | ||
| Testicular cancer | Yearly | ||
| Thyroid screening | Yearly | Yearly | Yearly |
Note: X implies recommendation for follow-up whenever the person is in contact with health care
Primary diagnoses on ICD code block level among 472 older adults (225 women and 247 men) with Down syndrome with at least one visit in planned and unplanned care. Only diagnoses within blocks recorded for at least 10 people are included (planned and unplanned separately)
| Planned | Unplanned | |||||||
|---|---|---|---|---|---|---|---|---|
| n (%) | Median | Q1-Q3 | Min-Max | n (%) | Median | Q1-Q3 | Min-Max | |
| Other bacterial diseases (A30-A49) | ||||||||
| Total | 1 (0.2) | 1 | 1–1 | 1–1 | 25 (5.3) | 1 | 1–1 | 1–4 |
| Women | 9 (4.0) | 1 | 1–1 | 1–1 | ||||
| Men | 16 (6.5) | 1 | 1–1 | 1–4 | ||||
| Diabetes mellitus (E10-E14) | ||||||||
| Total | 15 (3.2) | 1 | 1–3 | 1–11 | ||||
| Women | 8 (3.6) | 1 | 1–2 | 1–11 | ||||
| Men | 7 (2.8) | 2 | 1–3 | 1–3 | ||||
| Organic, including symptomatic, mental disorders (F00-F09) | ||||||||
| Total | 23 (4.9) | 1 | 1–1 | 1–2 | ||||
| Women | 14 (6.2) | 1 | 1–1 | 1–2 | ||||
| Men | 9 (3.6) | 1 | 1–1 | 1–2 | ||||
| Mental retardation (F70-F79) | ||||||||
| Total | 55 (11.7) | 1 | 1–2 | 1–6 | ||||
| Women | 28 (12.4) | 1 | 1–2 | 1–6 | ||||
| Men | 27 (10.9) | 1 | 1–3 | 1–6 | ||||
| Other degenerative diseases of the nervous system (G30-G32) | ||||||||
| Total | 14 (3.0) | 1 | 1–2 | 1–3 | ||||
| Women | 9 (4.0) | 1 | 1–2 | 1–2 | ||||
| Men | 5 (2.0) | 1 | 1–1 | 1–3 | ||||
| Episodic and paroxysmal disorders (G40-G47) | ||||||||
| Total | 43 (9.1) | 1 | 1–2 | 1–6 | 61 (12.9) | 1 | 1–2 | 1–30 |
| Women | 32 (14.2) | 1 | 1–2 | 1–6 | 39 (17.3) | 1 | 1–2 | 1–30 |
| Men | 11 (4.5) | 1 | 1–2 | 1–3 | 22 (8.9) | 1 | 1–1 | 1–4 |
| Disorders of conjunctiva (H10-H13) | ||||||||
| Total | 14 (3.0) | 1 | 1–1 | 1–4 | ||||
| Women | 7 (3.1) | 1 | 1–1 | 1–4 | ||||
| Men | 7 (2.8) | 1 | 1–1 | 1–1 | ||||
| Disorders of sclera, cornea, iris and ciliary body (H15-H22) | ||||||||
| Total | 24 (5.1) | 1 | 1–2 | 1–4 | ||||
| Women | 9 (4.0) | 2 | 1–2 | 1–4 | ||||
| Men | 15 (6.1) | 1 | 1–3 | 1–4 | ||||
| Disorders of lens (H25-H28) | ||||||||
| Total | 136 (28.8) | 1 | 1–2 | 1–4 | ||||
| Women | 80 (35.6) | 1 | 1–2 | 1–4 | ||||
| Men | 56 (22.7) | 1 | 1–2 | 1–3 | ||||
| Disorders of ocular muscles, binocular movement, accommo-dation and refraction (H49-H52) | ||||||||
| Total | 19 (4.0) | 1 | 1–1 | 1–3 | ||||
| Women | 13 (5.8) | 1 | 1–1 | 1–2 | ||||
| Men | 6 (2.4) | 1 | 1–1 | 1–3 | ||||
| Diseases of external ear (H60-H62) | ||||||||
| Total | 21 (4.4) | 1 | 1–2 | 1–7 | ||||
| Women | 9 (4.0) | 1 | 1–1 | 1–3 | ||||
| Men | 12 (4.9) | 1 | 1–2 | 1–7 | ||||
| Other disorders of ear (H90-H95) | ||||||||
| Total | 10 (2.1) | 1 | 1–1 | 1–2 | ||||
| Women | 3 (1.3) | 1 | 1–1 | 1–1 | ||||
| Men | 7 (2.8) | 1 | 1–1 | 1–2 | ||||
| Ischaemic heart diseases (I20-I25) | ||||||||
| Total | 11 (2.3) | 1 | 1–1 | 1–3 | ||||
| Women | 5 (2.2) | 1 | 1–1 | 1–3 | ||||
| Men | 6 (2.4) | 1 | 1–1 | 1–2 | ||||
| Other forms of heart disease (I30-I52) | ||||||||
| Total | 14 (3.0) | 1 | 1–1 | 1–2 | 25 (5.3) | 1 | 1–1 | 1–2 |
| Women | 6 (2.7) | 1 | 1–2 | 1–2 | 12 (5.3) | 1 | 1–1 | 1–1 |
| Men | 8 (3.2) | 1 | 1–1 | 1–1 | 13 (5.3) | 1 | 1–1 | 1–2 |
| Cerebrovascular diseases (I60-I69) | ||||||||
| Total | 19 (4.0) | 1 | 1–1 | 1–1 | ||||
| Women | 10 (4.4) | 1 | 1–1 | 1–1 | ||||
| Men | 9 (3.6) | 1 | 1–1 | 1–1 | ||||
| Acute upper respiratory infections(J00-J06) | ||||||||
| Total | 16 (3.4) | 1 | 1–1 | 1–3 | ||||
| Women | 6 (2.7) | 1 | 1–1 | 1–1 | ||||
| Men | 10 (4.0) | 1 | 1–1 | 1–3 | ||||
| Influenza and pneumonia (J09-J18) | ||||||||
| Total | 10 (2.1) | 1 | 1–1 | 1–2 | 118 (25.0) | 1 | 1–2 | 1–5 |
| Women | 4 (1.8) | 1 | 1–2 | 1–2 | 41 (18.2) | 1 | 1–2 | 1–5 |
| Men | 6 (2.4) | 1 | 1–1 | 1–1 | 77 (31.2) | 1 | 1–2 | 1–4 |
| Other acute lower respiratory infections (J20-J22) | ||||||||
| Total | 14 (3.0) | 1 | 1–1 | 1–2 | ||||
| Women | 9 (4.0) | 1 | 1–2 | 1–2 | ||||
| Men | 5 (2.0) | 1 | 1–1 | 1–1 | ||||
| Lung diseases due to external agents (J60-J70) | ||||||||
| Total | 13 (2.8) | 1 | 1–1 | 1–2 | ||||
| Women | 6 (2.7) | 1 | 1–1 | 1–2 | ||||
| Men | 7 (2.8) | 1 | 1–1 | 1–1 | ||||
| Diseases of oesophagus, stomach and duodenum (K20-K31) | ||||||||
| Total | 19 (4.0) | 1 | 1–1 | 1–2 | 21 (4.4) | 1 | 1–1 | 1–6 |
| Women | 8 (3.6) | 1 | 1–1 | 1–1 | 11 (4.9) | 1 | 1–1 | 1–6 |
| Men | 11 (4.5) | 1 | 1–1 | 1–2 | 10 (4.0) | 1 | 1–1 | 1–5 |
| Hernia (K40-K46) | ||||||||
| Total | 29 (6.1) | 1 | 1–2 | 1–2 | 12 (2.5) | 1 | 1–1 | 1–1 |
| Women | 6 (2.7) | 1 | 1–2 | 1–2 | 1 (0.4) | 1 | 1–1 | 1–1 |
| Men | 23 (9.3) | 1 | 1–2 | 1–2 | 11 (4.5) | 1 | 1–1 | 1–1 |
| Noninfective enteritis and colitis (K50-K52) | ||||||||
| Total | 11 (2.3) | 1 | 1–2 | 1–6 | ||||
| Women | 8 (3.6) | 1 | 1–3 | 1–6 | ||||
| Men | 3 (1.2) | 2 | 2–2 | 2–2 | ||||
| Other diseases of intestines (K55-K63) | ||||||||
| Total | 22 (4.7) | 1 | 1–2 | 1–5 | 30 (6.4) | 1 | 1–2 | 1–9 |
| Women | 16 (7.1) | 1 | 1–2 | 1–4 | 17 (7.6) | 1 | 1–2 | 1–9 |
| Men | 6 (2.4) | 1 | 1–2 | 1–5 | 13 (5.3) | 1 | 1–1 | 1–3 |
| Disorders of gallbladder, biliary tract and pancreas (K80-K87) | ||||||||
| Total | 12 (2.5) | 1 | 1–1 | 1–3 | ||||
| Women | 5 (2.2) | 1 | 1–1 | 1–3 | ||||
| Men | 7 (2.8) | 1 | 1–1 | 1–3 | ||||
| Other diseases of the digestive system (K90-K93) | ||||||||
| Total | 19 (4.0) | 1 | 1–1 | 1–3 | ||||
| Women | 6 (2.7) | 1 | 1–1 | 1–2 | ||||
| Men | 13 (5.3) | 1 | 1–1 | 1–3 | ||||
| Arthropathies (M00-M25) | ||||||||
| Total | 56 (11.9) | 2 | 2 | 6 | 27 (5.7) | 1 | 1 | 3 |
| Women | 37 (16.4) | 2 | 2 | 5 | 15 (6.7) | 1 | 1 | 3 |
| Men | 19 (7.7) | 1 | 2 | 6 | 12 (4.9) | 1 | 1 | 2 |
| Soft tissue disorders related to use, overuse and pressure (M70-M79) | ||||||||
| Total | 29 (6.1) | 1 | 1–1 | 1–2 | ||||
| Women | 15 (6.7) | 1 | 1–1 | 1–2 | ||||
| Men | 14 (5.7) | 1 | 1–1 | 1–2 | ||||
| Disorders of bone density and structure (M80-M85) | ||||||||
| Total | 11 (2.3) | 2 | 1–2 | 1–3 | ||||
| Women | 6 (2.7) | 2 | 1–2 | 1–3 | ||||
| Men | 5 (2.0) | 2 | 2–2 | 1–2 | ||||
| Renal tubulo-interstitial diseases (N10-N16) | ||||||||
| Total | 11 (2.3) | 1 | 1–1 | 1–2 | ||||
| Women | 4 (1.8) | 1 | 1–1 | 1–1 | ||||
| Men | 7 (2.8) | 1 | 1–1 | 1–2 | ||||
| Other diseases of urinary system (N30-N39) | ||||||||
| Total | 39 (8.3) | 1 | 1–1 | 1–6 | ||||
| Women | 20 (8.9) | 1 | 1–2 | 1–6 | ||||
| Men | 19 (7.7) | 1 | 1–1 | 1–2 | ||||
| Non-inflammatory disorders of female genital tract (N80-N98) | ||||||||
| Total | 12 (2.5) | 1 | 1–1 | 1–1 | ||||
| Women | 12 (5.3) | 1 | 1–1 | 1–1 | ||||
| Men | 0 (0) | |||||||
| Congenital malformations of the circulatory system (Q20-Q28) | ||||||||
| Total | 10 (2.1) | 1 | 1–2 | 1–5 | ||||
| Women | 5 (2.2) | 1 | 1–1 | 1–2 | ||||
| Men | 5 (2.0) | 2 | 1–2 | 1–5 | ||||
| Chromosomal abnormalities, not elsewhere classified (Q90-Q99) | ||||||||
| Total | 108 (22.9) | 1 | 1–1 | 1–3 | 33 (7.0) | 1 | 1–1 | 1–3 |
| Women | 53 (23.6) | 1 | 1–1 | 1–3 | 19 (8.4) | 1 | 1–1 | 1–2 |
| Men | 55 (22.3) | 1 | 1–1 | 1–3 | 14 (5.7) | 1 | 1–1 | 1–3 |
| Symptoms and signs involving the circulatory and respiratory systems (R00-R09) | ||||||||
| Total | 29 (6.1) | 1 | 1–1 | 1–7 | ||||
| Women | 8 (3.6) | 2 | 1–3 | 1–7 | ||||
| Men | 21 (8.5) | 1 | 1–1 | 1–3 | ||||
| Symptoms and signs involving the digestive system and abdomen (R10-R19) | ||||||||
| Total | 18 (3.8) | 1 | 1–1 | 1–4 | 64 (13.6) | 1 | 1–1 | 1–25 |
| Women | 12 (5.3) | 1 | 1–2 | 1–4 | 35 (15.6) | 1 | 1–2 | 1–25 |
| Men | 6 (2.4) | 1 | 1–1 | 1–1 | 29 (11.7) | 1 | 1–1 | 1–2 |
| General symptoms and signs (R50- R69) | ||||||||
| Total | 68 (14.4) | 1 | 1–1 | 1–5 | ||||
| Women | 38 (16.9) | 1 | 1–1 | 1–5 | ||||
| Men | 30 (12.1) | 1 | 1–1 | 1–2 | ||||
| Injuries to the head (S00-S09) | ||||||||
| Total | 29 (6.1) | 1 | 1–1 | 1–3 | ||||
| Women | 19 (8.4) | 1 | 1–1 | 1–3 | ||||
| Men | 10 (4.0) | 1 | 1–1 | 1–3 | ||||
| Injuries to abdomen, lower back, lumbar spine and pelvis (S30-S39) | ||||||||
| Total | 10 (2.1) | 1 | 1–1 | 1–2 | ||||
| Women | 7 (3.1) | 1 | 1–2 | 1–2 | ||||
| Men | 3 (1.2) | 1 | 1–1 | 1–1 | ||||
| Injuries to the shoulder and upper arm (S40-S49) | ||||||||
| Total | 10 (2.1) | 1 | 1–1 | 1–2 | 15 (3.2) | 1 | 1–1 | 1–2 |
| Women | 7 (3.1) | 1 | 1–1 | 1–2 | 10 (4.4) | 1 | 1–1 | 1–1 |
| Men | 3 (1.2) | 1 | 1–1 | 1–1 | 5 (2.0) | 1 | 1–1 | 1–2 |
| Injuries to the elbow and forearm (S50-S59) | ||||||||
| Total | 14 (3.0) | 1 | 1–1 | 1–2 | ||||
| Women | 7 (3.1) | 1 | 1–2 | 1–2 | ||||
| Men | 7 (2.8) | 1 | 1–1 | 1–1 | ||||
| Injuries to the hip and thigh (S70-S79) | ||||||||
| Total | 16 (3.4) | 1 | 1–2 | 1–2 | 53 (11.2) | 1 | 1–2 | 1–3 |
| Women | 12 (5.3) | 1 | 1–2 | 1–2 | 26 (11.6) | 1 | 1–2 | 1–3 |
| Men | 4 (1.6) | 1 | 1–1 | 1–1 | 27 (10.9) | 1 | 1–1 | 1–2 |
| Injuries to the knee and lower leg (S80-S89) | ||||||||
| Total | 23 (4.9) | 1 | 1–1 | 1–2 | 39 (8.3) | 1 | 1–1 | 1–4 |
| Women | 13 (5.8) | 1 | 1–1 | 1–2 | 28 (12.4) | 1 | 1–1 | 1–4 |
| Men | 10 (4.0) | 1 | 1–1 | 1–2 | 11 (4.5) | 1 | 1–2 | 1–3 |
| Injuries to the ankle and foot (S90-S99) | ||||||||
| Total | 20 (4.2) | 1 | 1–1 | 1–1 | ||||
| Women | 9 (4.0) | 1 | 1–1 | 1–1 | ||||
| Men | 11 (4.5) | 1 | 1–1 | 1–1 | ||||
| Effects of foreign body entering through natural orifice (T15-T19) | ||||||||
| Total | 24 (5.1) | 1 | 1–1 | 1–2 | ||||
| Women | 7 (3.1) | 1 | 1–1 | 1–2 | ||||
| Men | 17 (6.9) | 1 | 1–1 | 1–2 | ||||
| Health services for examination and investigation (Z00-Z13) | ||||||||
| Total | 62 (13.1) | 1 | 1–1 | 1–3 | 19 (4.0) | 1 | 1–1 | 1–3 |
| Women | 36 (16.0) | 1 | 1–1 | 1–3 | 6 (2.7) | 1 | 1–2 | 1–3 |
| Men | 26 (10.5) | 1 | 1–1 | 1–2 | 13 (5.3) | 1 | 1–1 | 1–1 |
| Health services for specific proce-dures and health care (Z40-Z54) | ||||||||
| Total | 12 (2.5) | 1 | 1–1 | 1–6 | ||||
| Women | 5 (2.2) | 1 | 1–1 | 1–1 | ||||
| Men | 7 (2.8) | 1 | 1–1 | 1–6 | ||||
| Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z80-Z99) | ||||||||
| Total | 17 (3.6) | 1 | 1–1 | 1–4 | ||||
| Women | 10 (4.4) | 1 | 1–2 | 1–4 | ||||
| Men | 7 (2.8) | 1 | 1–1 | 1–1 | ||||